← Open Payments lookup

LARRY FLOWERS: Open Payments

NPI 1750336707 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,522 in 56 payments from 11 companies in 2025. Trend: 2023 $599 · 2024 $595 · 2025 $1,522

Food & beverage: $1,522
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.21$555
E.R. Squibb & Sons, L.L.C.4$250
Neurocrine BioSciences, Inc.10$220
Alkermes, Inc.6$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$111
ABBVIE INC.3$82
Otsuka America Pharmaceutical, Inc.2$52
Janssen Pharmaceuticals, Inc2$44
HARMONY BIOSCIENCES LLC1$26
Validus Pharmaceuticals LLC1$23

Products named: UZEDY, COBENFY, INGREZZA, ARISTADA, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.